Biogen (BIIB) Non Operating Income (2009 - 2022)

Biogen's Non Operating Income history runs 14 years deep, the most recent figure standing at -$263.3 million for Q1 2022.

• In Q1 2022, Non Operating Income rose 48.06% year-over-year to -$263.3 million; the TTM figure through Mar 2022 stood at -$851.9 million (down 867.48% YoY), while the FY2025 annual figure was -$305.6 million, up 11.06% from the prior year.
• Non Operating Income was -$263.3 million for Q1 2022 at Biogen, down from -$182.1 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $683.5 million in Q4 2020 to a low of -$506.9 million in Q1 2021.
• Historically, Non Operating Income has averaged -$45.1 million across 5 years, with a median of -$41.0 million in 2018.
• The sharpest annual moves came in 2019 and 2020: Non Operating Income tumbled 472.17% in 2019, then soared 1486.41% in 2020.
• A 5-year view of Non Operating Income shows it stood at -$28.6 million in 2018, then slumped by 72.38% to -$49.3 million in 2019, then jumped by 1486.41% to $683.5 million in 2020, then slumped by 126.64% to -$182.1 million in 2021, then tumbled by 44.59% to -$263.3 million in 2022.
• The last three Non Operating Income figures came in at -$263.3 million (Q1 2022), -$182.1 million (Q4 2021), and -$502.9 million (Q3 2021), per Business Quant data.